Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aldeyra Therapeutics Inc. logo

Aldeyra Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.79
 
USD
  
0.02
  
(0.72%)
Optionable: Yes  Market Cap: 177 M  90-day average vol: 771,310

Previous close: 2.77  Open: 2.71  Bid: 2.79  Ask: 2.92
52 week range    
1.42   
   11.97
Peers   
ANTH / 
TENX / 
Last updated: Monday 18th March 2024
37
MarketXLS Rank
60
Value
30
Technical
23
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ANTH

REGN

66 B9.7622.36

TENX

0 B-0.30.7312
Financials

ALDX Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock333082.0
AccruedPreferredStockDividends4 M
Basic EPS from continuing operations-1.11-1.07
Basic EPS total-2.51-1.4-1.11-1.07-1.06
Basic weighted shares outstanding4 M9 M11 M16 M22 M27 M34 M54 M58 M
Diluted EPS total-3.09-1.4-1.65-1.4-1.79-2.24-1.11-1.07-1.06
Diluted weighted shares outstanding4 M9 M11 M16 M22 M27 M34 M54 M58 M
GeneralAndAdministrativeExpense4 M4 M6 M6 M10 M12 M10 M11 M15 M
Income before tax-5 M-12 M-19 M-22 M-39 M-62 M-38 M-58 M-62 M
Income taxes-1 M-479265.0
Interest income3.011126.0102037.0261252.0952698.02 M292224.0185363.02 M
InterestExpenseNonOperating244174.0112306.0105509.0113453.0146792.0603846.02 M2 M2 M
MiscOtherSpecialCharges2 M
Net income from total operations-5 M-12 M-19 M-22 M-39 M-61 M-38 M-58 M-62 M
NetIncomeCommonStockholders-10 M-12 M-19 M-22 M-39 M-61 M-34 M-58 M-62 M
NetIncomeContinuousOperations-5 M-12 M-19 M-22 M-39 M-61 M-38 M-58 M-62 M
NetNonOperatingInterestIncomeExpense-244171.0-101180.0-3472.0147799.0805906.0937503.0-2 M-2 M655351.0
Operating income-7 M-12 M-19 M-22 M-40 M-63 M-36 M-56 M-63 M
Operating income before depreciation (EBITDA)-5 M-12 M-18 M-22 M-39 M-62 M-36 M-55 M-60 M
OperatingExpense7 M12 M19 M22 M40 M63 M33 M56 M63 M
Other income net-2 M
OtherGandA4 M4 M6 M6 M10 M12 M10 M11 M15 M
OtherOperatingExpenses200000.0
OtherunderPreferredStockDividend4 M
PreferredStockDividends4 M
RentAndLandingFees4 M4 M6 M6 M10 M12 M15 M
Research & development expense4 M8 M13 M16 M30 M44 M25 M45 M47 M
ResearchExpense4 M8 M13 M16 M30 M44 M25 M45 M47 M
SalariesAndWages-4 M7 M-2 M400000.0-8 M
Selling Gen & administrative expense4 M4 M6 M6 M10 M12 M10 M11 M15 M
Total Income available for interest expense (EBIT)-5 M-12 M-19 M-22 M-39 M-62 M-36 M-56 M-60 M
Total common shares outstanding7 M10 M15 M20 M27 M30 M47 M58 M59 M
Total net income-5 M-12 M-19 M-22 M-39 M-61 M-38 M-58 M-62 M
Total ordinary shares59 M59 M59 M59 M59 M59 M59 M59 M59 M
TotalExpenses7 M12 M19 M22 M40 M63 M33 M56 M63 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University